---
figid: PMC9454615__fphys-13-960308-g005
figtitle: 'Impact of COVID-19 on populations living at high altitude: Role of hypoxia-inducible
  factors (HIFs) signaling pathway in SARS-CoV-2 infection and replication'
organisms:
- Human immunodeficiency virus 1
- Severe acute respiratory syndrome coronavirus 2
- Coronaviridae
- Severe acute respiratory syndrome-related coronavirus
- Human betaherpesvirus 5
- H1N1 subtype
- DNA viruses
- ssRNA viruses
- dsRNA viruses
- Mus musculus
- Rattus norvegicus
- Cavia porcellus
- Oryctolagus cuniculus
- Ovis aries
- Curcuma longa
- Lens culinaris
- Homo sapiens
organisms_ner:
- Mus musculus
- Ovis aries
- Rattus norvegicus
- Cavia porcellus
- Homo sapiens
- Oryctolagus cuniculus
- Drosophila melanogaster
pmcid: PMC9454615
filename: fphys-13-960308-g005.jpg
figlink: /pmc/articles/PMC9454615/figure/F5/
number: F5
caption: 'Schematic diagram illustrating six of the potential curcumin targets during
  SARS-CoV-2 infection of susceptible cells with a specific focus on: Left: viral
  entry pathway (right panel, targets 1–3) and, Right: Ang II induced hypoxia pathway
  (left panel, targets 4–6). Regarding the viral entry pathway, curcumin prevents
  the binding of the SARS-CoV-2 S protein to the ACE2 receptor by binding to both
  proteins (1,2). In addition, curcumin prevents endosomal acidification required
  for the initiation of viral replication (3). Regarding the Ang II pathway, curcumin
  inhibit ACE1 (4), thus preventing the accumulation of Ang II. Moreover, curcumin
  prevents hypoxia-induced HIF1-α upregulation (5) and p300 acetyl transferase activity
  within the HIF1-α/β/CBP-p300 complex (6). Upper left, chemical structure of curcumin
  (diferuloylmethane). Effects of curcumin on Trp ion channels such as TrpA1 and TrpV1,
  have also been reported (not shown). ACE: Angiotensin converting enzyme; Ang: Angiotensin;
  AT1R: Ang II type I receptor; CBP/p300: Histone acetyltransferases CREB Binding
  Protein (CBP)/p300; IRF: Interferon regulatory factor; MDA: Melanoma differentiation-associated
  gene; MVAs: Mitochondrial antiviral-signal protein; RIG: Retinoic acid inducible
  gene; TMPRSS2: Transmembrane serine protease two; TLR: Toll like receptor; TRAF:
  Tumour necrosis factor receptor-associated factor; TRIF: TIR-domain-containing adapter-inducing
  interferon.'
papertitle: 'The impact of COVID-19 on populations living at high altitude: Role of
  hypoxia-inducible factors (HIFs) signaling pathway in SARS-CoV-2 infection and replication.'
reftext: Christian Albert Devaux, et al. Front Physiol. 2022;13:960308.
year: '2022'
doi: 10.3389/fphys.2022.960308
journal_title: Frontiers in Physiology
journal_nlm_ta: Front Physiol
publisher_name: Frontiers Media S.A.
keywords: COVID-19 | hypoxia | hypoxia-inducible factors | Nrf2 | TRPA1 | curcumin
automl_pathway: 0.9702687
figid_alias: PMC9454615__F5
figtype: Figure
redirect_from: /figures/PMC9454615__F5
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9454615__fphys-13-960308-g005.html
  '@type': Dataset
  description: 'Schematic diagram illustrating six of the potential curcumin targets
    during SARS-CoV-2 infection of susceptible cells with a specific focus on: Left:
    viral entry pathway (right panel, targets 1–3) and, Right: Ang II induced hypoxia
    pathway (left panel, targets 4–6). Regarding the viral entry pathway, curcumin
    prevents the binding of the SARS-CoV-2 S protein to the ACE2 receptor by binding
    to both proteins (1,2). In addition, curcumin prevents endosomal acidification
    required for the initiation of viral replication (3). Regarding the Ang II pathway,
    curcumin inhibit ACE1 (4), thus preventing the accumulation of Ang II. Moreover,
    curcumin prevents hypoxia-induced HIF1-α upregulation (5) and p300 acetyl transferase
    activity within the HIF1-α/β/CBP-p300 complex (6). Upper left, chemical structure
    of curcumin (diferuloylmethane). Effects of curcumin on Trp ion channels such
    as TrpA1 and TrpV1, have also been reported (not shown). ACE: Angiotensin converting
    enzyme; Ang: Angiotensin; AT1R: Ang II type I receptor; CBP/p300: Histone acetyltransferases
    CREB Binding Protein (CBP)/p300; IRF: Interferon regulatory factor; MDA: Melanoma
    differentiation-associated gene; MVAs: Mitochondrial antiviral-signal protein;
    RIG: Retinoic acid inducible gene; TMPRSS2: Transmembrane serine protease two;
    TLR: Toll like receptor; TRAF: Tumour necrosis factor receptor-associated factor;
    TRIF: TIR-domain-containing adapter-inducing interferon.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Nfkbib
  - Nfkb1
  - Traf6
  - Traf3
  - Irf7
  - Myd88
  - Rnf138
  - Trim69
  - Ticam1
  - Ticam2
  - Apela
  - wam
  - Tlr3
  - Tmprss2
  - Irf3
  - Ie
  - Rig1
  - Robo3
  - Ep300
  - Agtrap
  - Ang3
  - Angpt1
  - Ang
  - Tm7sf2
  - Agt
  - Trpa1
  - Hif1a
  - NFKB2
  - TRAF6
  - TRAF3
  - IRF7
  - MYD88
  - TLR3
  - TMPRSS2
  - IRF3
  - RIGI
  - AGTR1
  - ANG-1
  - ANGPT1
  - TRPA1
  - ANG-2
  - ANGPT2
  - HIF1A
  - Rela
  - Agtr1a
  - Angpt2
  - NFKB1
  - RELA
  - RELB
  - REL
  - TRIM69
  - TICAM1
  - APELA
  - IFNK
  - IFNW1
  - IFNA1
  - IFNA2
  - IFNA4
  - IFNA5
  - IFNA6
  - IFNA7
  - IFNA8
  - IFNA10
  - IFNA13
  - IFNA14
  - IFNA16
  - IFNA17
  - IFNA21
  - IFNB1
  - PLAAT4
  - ROBO3
  - EP300
  - ACE
  - TM7SF2
  - VPS51
  - ACE-1
  - Dif
  - dl
  - Rel
  - Traf-like
  - un
  - ww
  - Chi
  - chic
  - osa
  - nej
  - ACE1
  - Cp38
  - CkIIbeta
  - Andorra
  - Anp
  - Acam
  - TrpA1
  - sima
---
